Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), traditionally recognized for glycemic regulation and weight management, exhibit renoprotective effects in DKD through multifactorial mechanisms. The gene discussed is GLP1R; the disease is diabetic kidney disease.